FindTrial
Sign In

Effect of double lumen bronchial catheter and bronchial occlusion device on myocardial enzyme profile after thoracic surgery in patients with coronary heart disease

Effect of double lumen bronchial catheter and bronchial occlusion device on myocardial enzyme profile after thoracic surgery in patients with coronary heart disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042359
Enrollment
Unknown
Registered
2021-01-21
Start date
2021-02-10
Completion date
Unknown
Last updated
2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial injury

Interventions

Bronchial Blocker:Use Bronchial Blocker
double-lumen endobronchial tube:Use double-lumen endobronchial tube

Sponsors

Naval Medical Center, PLA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with coronary heart disease who plan to undergo pulmonary and esophageal surgery; Age: 18-80 years; ASA I - III level.

Exclusion criteria

Exclusion criteria: Pregnancy; A long history of opioid treatment, abuse and drug use; Refuse to participate in the experiment.

Design outcomes

Primary

MeasureTime frame
Myocardial enzyme spectrum;—

Countries

China

Contacts

Public ContactZhengyu Jiang

Naval Medical Center, PLA

jzysmmu@outlook.com+86 13166115160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026